Ryunosuke Nakagawa Selected Research

Ryunosuke Nakagawa Research Topics

8	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 09/2022
5	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 09/2022
5	Neoplasms (Cancer) 04/2024 - 09/2022
4	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2020
2	Carcinoma (Carcinomatosis) 12/2021 - 03/2021
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 10/2019
1	Hypotension (Low Blood Pressure) 04/2024
1	Non-Muscle Invasive Bladder Neoplasms 06/2023
1	Pneumoperitoneum 09/2022
1	Air Embolism (Gas Embolism) 09/2022
1	Embolism (Embolus) 09/2022
1	Lymphocele 09/2021
1	Neutropenia 01/2021
1	Plasma Cell Granuloma 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Rhabdomyosarcoma 10/2019
1	Testicular Neoplasms (Testicular Cancer) 10/2019
1	Prostatitis 05/2019
1	Disease Progression 05/2019

3	Biomarkers (Surrogate Marker)IBA 11/2022 - 03/2021
2	Androgen Receptors (Androgen Receptor)IBA 04/2023 - 03/2023
2	Hormones (Hormone)IBA 03/2023 - 10/2022
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2022 - 09/2022
2	LigandsIBA 11/2022 - 09/2022
2	CC ChemokinesIBA 11/2022 - 09/2022
2	pembrolizumabIBA 12/2021 - 03/2021
1	AcidsIBA 04/2024
1	Procollagen Type IIBA 01/2024
1	Tartrate-Resistant Acid PhosphataseIBA 01/2024
1	Chalcone (Benzalacetophenone)IBA 06/2023
1	AndrogensIBA 06/2023
1	Small Interfering RNA (siRNA)IBA 04/2023
1	Carbon DioxideIBA 09/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	indium-bleomycinIBA 01/2021
1	pegfilgrastim (Neulasta)FDA Link 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 10/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 05/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 05/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019

7	Castration 01/2024 - 09/2022
6	Therapeutics 06/2023 - 01/2021
5	Transurethral Resection of Bladder 04/2024 - 09/2022
2	Nephrectomy 09/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2019
1	Spinal Anesthesia 04/2024
1	Oral Administration 04/2024
1	General Anesthesia 04/2024
1	Patient Readmission 02/2024
1	Cystectomy 02/2024
1	Conservative Treatment 02/2024
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2022
1	Lymph Node Excision (Lymph Node Dissection) 09/2021
1	Aftercare (After-Treatment) 10/2019
1	Antibiotic Prophylaxis 05/2019